ArticleEBioMedicine2020

cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation?

Nicola Normanno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.